1. Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists

   • Alice B. Gottlieb
   • Alvin F. Wells
   • Joseph F. Merola

   Review Article Open access 26 January 2022 Pages: 1271 - 1283

2. Assessing the burden of osteoarthritis in Latin America: a rapid evidence assessment

   • Daniel Ciampi de Andrade
   • Diego Saaibi
   • Rolando Espinosa

   Review Article Open access 29 January 2022 Pages: 1285 - 1292

   

3. Neglected tropical rheumatic diseases

   • Rasmi Ranjan Sahoo
   • Anupam Wakhlu
   • Vikas Agarwal

   Review Article 10 February 2022 Pages: 1293 - 1304

   

4. Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis

   • Gaizhi Zhu
   • Shan Zhou
   • Renxi Wang

   Original Article 08 January 2022 Pages: 1305 - 1312

   

5. Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis

   • Yang Liu
   • Jun Jiang
   • Kailong Yu

   Original Article 10 January 2022 Pages: 1313 - 1322

   

6. Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis

   • Guy Katz
   • Alexis Ogdie
   • Michael D. George

   Original Article 27 January 2022 Pages: 1323 - 1331

   

7. Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: connecting pieces of the puzzle

   • Manar R. Senosi
   • Hanan M. Fathi
   • Tamer A. Gheita

   Original Article Open access 19 January 2022 Pages: 1333 - 1342

   

8. Bone erosions by MRI in first-degree relatives of patients with RA: an exploratory study

   • David Vega-Morales
   • María del Carmen Larios-Forte
   • Dionicio Ángel Galarza-Delgado

   Original Article 28 January 2022 Pages: 1343 - 1348

9. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

   • Ernesto Zavala-Flores
   • Jannin Salcedo-Matienzo
   • Alfredo Berrocal-Kasay

   Brief Report 16 November 2021 Pages: 1349 - 1357

   

10. Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population

    • Fatma Dhaffouli
    • Hend Hachicha
    • Hatem Masmoudi

    Original Article 14 January 2022 Pages: 1359 - 1369

    

11. The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV)

    • Yufang Ding
    • Jiuliang Zhao
    • Xiaofeng Zeng

    Original Article 27 January 2022 Pages: 1371 - 1379

    

12. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis

    • Nuh Atas
    • Bağdagül Çakır
    • Abdurrahman Tufan

    Original Article 20 January 2022 Pages: 1381 - 1389

    

13. Development of a screening tool to identify patients with axial spondyloarthritis: a cognitive interview study

    • Divya Shridharmurthy
    • Sara Khan
    • Shao-Hsien Liu

    Original Article 21 January 2022 Pages: 1391 - 1402

14. Presence of subclinical inflammation in axial spondyloarthritis patients with NSAID/anti-TNF-α drug-induced clinical remission

    • He-xiang Zong
    • Sheng-qian Xu
    • Xi-le Wang

    Original Article 27 January 2022 Pages: 1403 - 1412

    

15. Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients

    • Dionicio A. Galarza-Delgado
    • Jose R. Azpiri-Lopez
    • Andrea C. Garza-Acosta

    Brief Report 26 November 2021 Pages: 1413 - 1420

16. Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

    • L. Widawski
    • T. Fabacher
    • R. Felten

    Original Article Open access 20 January 2022 Pages: 1421 - 1429

    

17. Exploring cannabis use and perspectives among psoriatic disease patients

    • Jackie Tsang
    • Orli Silverberg
    • Cheryl F. Rosen

    Original Article 20 January 2022 Pages: 1431 - 1437

18. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

    • Gizem Ayan
    • Bayram Farisogulları
    • Umut Kalyoncu

    Original Article 27 January 2022 Pages: 1439 - 1446

    

19. Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies’ types and titers—cross-sectional study of Serbian cohort

    • Aleksandra Djokovic
    • Ljudmila Stojanovich
    • Jovica Saponjski

    Original Article 11 January 2022 Pages: 1447 - 1455

    

20. Indications and risk factors for hospitalization in patients with primary Sjögren syndrome: experience from a tertiary center in Turkey

    • Müçteba Enes Yayla
    • Didem Şahin Eroğlu
    • Gülay Kınıklı

    Original Article 06 January 2022 Pages: 1457 - 1463

21. Abnormal Histones Acetylation in Patients with Primary Sjögren's Syndrome

    • Xiuying Lv
    • Mi Zhou
    • Yan Li

    Original Article 29 January 2022 Pages: 1465 - 1472

    

22. Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study

    • Koichi Yamaguchi
    • Takahito Nakajima
    • Toshitaka Maeno

    Original Article 16 January 2022 Pages: 1473 - 1481

    

23. Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement

    • Alice Delapierre
    • Benjamin Terrier
    • on behalf of the French Vasculitis Study Group (FVSG) and the HSPrognosis group

    Original Article 18 January 2022 Pages: 1483 - 1491

    

24. Palpable purpura: is it associated with vasculitis or not? A single-center experience

    • Gizem Kaynar Özçelik
    • Ozan Cemal Içaçan
    • Cemal Bes

    Original Article 25 January 2022 Pages: 1493 - 1498

    

25. Imaging features of ¹⁸F-FDG PET/CT in different types of systemic vasculitis

    • Zhuo Chen
    • Yunyun Zhao
    • Yunshan Zhou

    Original Article 28 January 2022 Pages: 1499 - 1509

    

26. Genotype–phenotype associations in familial Mediterranean fever: a study of 500 Egyptian pediatric patients

    • Amal El Beshlawy
    • Abd El Rahman Zekri
    • Gaafar Ragab

    Original Article 06 January 2022 Pages: 1511 - 1521

    

27. Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children

    • Fatih Haslak
    • Dogukan Ozbey
    • Kenan Barut

    Original Article 19 January 2022 Pages: 1523 - 1533

    

28. The expanded spectrum of arthritis in children with familial Mediterranean fever

    • Pinar Ozge Avar-Aydın
    • Zeynep Birsin Ozcakar
    • Fatos Yalcınkaya

    Original Article 28 January 2022 Pages: 1535 - 1541

29. The value of 68 Ga-PSMA-11 positron emission tomography/computerized tomography in evaluating the lacrimal and salivary glands function

    • Jian-fang Li
    • Lu-ping Qin
    • Liang-jun Xie

    Original Article 28 January 2022 Pages: 1543 - 1550

    

30. Dysfunction of CD27⁺IgD⁺ B cells correlates with aggravated systemic lupus erythematosus

    • Wei Zhang
    • Yong-Fu Wang
    • Ke Li

    Original Article 15 January 2022 Pages: 1551 - 1559

    

31. Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis

    • Rebecca Heijke
    • Mathilda Björk
    • Christopher Sjöwall

    Brief Report Open access 27 November 2021 Pages: 1561 - 1568

    

32. New-onset Adult-onset Still’s disease-like syndrome after ChAdOx1 nCoV-19 vaccination—a case series with review of literature

    • Shivraj Padiyar
    • Navaneeth Kamath
    • Arvind Ganapati

    Case Based Review 18 January 2022 Pages: 1569 - 1575

    

33. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review

    • Alrashdi Mousa N
    • Alanazi Majed Saleh
    • Sultan Mahja Marzouq Alanazi

    Case Based Review 17 February 2022 Pages: 1577 - 1582

    

34. Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature

    • Ji-Won Kim
    • Ju-Yang Jung
    • Hyoun-Ah Kim

    Case Based Review 19 February 2022 Pages: 1583 - 1589

    

35. Two flares of Still’s disease after two doses of the ChAdOx1 vaccine

    • Rashmi Roongta
    • Sumantro Mondal
    • Alakendu Ghosh

    Case Based Review 06 March 2022 Pages: 1591 - 1596

    

36. Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report

    • Chantal Lemoine
    • Cristina Padilla
    • Rohit Aggarwal

    Case Based Review 16 March 2022 Pages: 1597 - 1601

37. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?

    • Luis J. Jara
    • Olga Vera-Lastra
    • Yehuda Shoenfeld

    Perspectives in Rheumatology 05 April 2022 Pages: 1603 - 1609

38. Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination

    • Ian Liang
    • Sanjay Swaminathan
    • Adrian Y. S. Lee

    Clinical Image 02 October 2021 Pages: 1611 - 1612

    

39. Ocular manifestation in gout: an unusual presentation of gout

    • Javier Barranco-Trabi
    • Victoria Mank
    • Jefferson Roberts

    Clinical Image 29 January 2022 Pages: 1613 - 1614

    

40. Poncet’s disease: a reactive arthritis secondary to pulmonary tuberculosis

    • Matheo Augusto Morandi Stumpf
    • José Moreira Kffuri Filho
    • Arnaldo Lichtenstein

    Clinical Image 02 February 2022 Pages: 1615 - 1616

    

41. Radiographic Findings of Lupus Related Entero-colitis

    • Pooja Mahesh Jotwani
    • Anish Vinit Patel

    Clinical Image 19 February 2022 Pages: 1617 - 1618

    

42. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

    • Medha Barbhaiya
    • Jonah M. Levine
    • Lisa A. Mandl

    Letters of Biomedical and Clinical Research 30 October 2021 Pages: 1619 - 1622

43. New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?

    • Ana M. Anzola
    • Laura Trives
    • Juan Molina-Collada

    Letter to the Editor 03 February 2022 Pages: 1623 - 1625